MARKET

DRUG

DRUG

Bright Minds Biosciences Inc
NASDAQ
77.90
-2.67
-3.31%
After Hours: 77.90 0 0.00% 17:21 02/13 EST
OPEN
80.83
PREV CLOSE
80.57
HIGH
82.88
LOW
74.21
VOLUME
74.11K
TURNOVER
--
52 WEEK HIGH
123.75
52 WEEK LOW
23.18
MARKET CAP
758.14M
P/E (TTM)
-60.9880
1D
5D
1M
3M
1Y
5Y
1D
De-Risked Neurology Pipeline and Pivotal 2026 Catalysts Underpin Buy Rating on BMB-101 Franchise
TipRanks · 1d ago
Bright Minds price target lowered to $126 from $142 at Baird
TipRanks · 1d ago
Bright Minds Biosciences Files Q1 FY2026 Financials Showing Strong Cash, Higher R&D Loss
TipRanks · 1d ago
Bright Minds Biosciences Reports Q4 Net Loss of CAD 7.57 Million
Reuters · 1d ago
Weekly Report: what happened at DRUG last week (0202-0206)?
Weekly Report · 5d ago
BTIG Sticks to Its Buy Rating for Bright Minds Biosciences (DRUG)
TipRanks · 02/03 02:47
Weekly Report: what happened at DRUG last week (0126-0130)?
Weekly Report · 02/02 09:23
Weekly Report: what happened at DRUG last week (0119-0123)?
Weekly Report · 01/26 09:23
More
About DRUG
Bright Minds Biosciences Inc. is a biotechnology company, which is engaged in developing treatments for patients with neurological and psychiatric disorders. The Company is focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders. Its Serotonin (5-HT) is a neurotransmitter in the brain and modulates many biological functions. Dysfunction of serotonin receptors, transporters, and associated neurocircuits is fundamental to many diseases including epilepsies and neuro psychiatric. Its pipeline includes BMB-101, BMB-xxx, BMB-201, and BMB-202. The Company has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling.

Webull offers Bright Minds Biosciences Inc stock information, including NASDAQ: DRUG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DRUG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DRUG stock methods without spending real money on the virtual paper trading platform.